• Transparency Seal
  • Major Programs & Projects
  • Contact Us
Republic of Philippines - Office of the President
  • About DDB
    • DDB History
    • Mandate
    • Composition of the Board
    • Officials
    • The DDB Secretariat
    • DDB Hymn
    • RA 9165
    • FAQs
  • Preventive Education
    • Preventive Education and Advocacy Programs
    • Request for IEC Materials
    • Request for Capacity Building and Advocacy Programs
  • Legal Services
    • Treatment and Rehabilitation
    • Regulatory Control
  • Research & Statistics
    • Statistics
    • Researches
      • Drug Smuggling in the Philippines
      • Social and Economic Cost Allowing Access to Medical Cannabis
      • Effectiveness of the DARE Program
  • Issuances
    • Board Regulations
    • Board Resolutions
Select Page

Advisory for July 02, 2023

by Mapru Admin | Jul 3, 2023 | Advisory | 0 comments

The Dangerous Drugs Board is not affiliated with or does not have any kind of business relationship with DDB Group Philippines.

Search

Recent Posts

  • DDB STRENGTHENS HEALTH AND WELL-BEING SYSTEMS IN HIGHER EDUCATION DURING THE ZONAL PUBLIC ORIENTATION ON CHED CMO NO. 5, S. 2026 FOR LUZON CLUSTER
  • DDB RECEIVES ₱10 MILLION MANDATORY CONTRIBUTION FROM PAGCOR TO EXPAND RECOVERY SERVICES ACROSS THE COUNTRY
  • DDB BUILDS LOCAL CAPACITY FOR DRUG PREVENTION IN MANDAUE CITY THROUGH CBAIDA TRAINING
  • DDBUNKS SERIES EPISODE 1: NAHULI, KULONG AGAD?
  • INTRODUCTION OF DDBUNKS SERIES FOR IDADAIT 2026

REPUBLIC OF THE PHILIPPINES

All content is in the public domain unless otherwise stated.

ABOUT GOVPH

Learn more about the Philippine government, its structure, how government works and the people behind it.

  • GOV.PH
  • Open Data Portal
  • Official Gazette

GOVERNMENT LINKS

  • Office of the President
  • Office of the Vice President
  • Senate of the Philippines
  • House of Representatives
  • Supreme Court
  • Court of Appeals
  • Sandiganbayan

 

×
X
CAPTCHA Image